These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24721755)

  • 41. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive value of platelet reactivity unit (PRU) value for thrombotic and hemorrhagic events during flow diversion procedures: a meta-analysis.
    Ajadi E; Kabir S; Cook A; Grupke S; Alhajeri A; Fraser JF
    J Neurointerv Surg; 2019 Nov; 11(11):1123-1128. PubMed ID: 31005859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired responsiveness to clopidogrel and aspirin in patients with recurrent stent thrombosis following percutaneous intervention for peripheral artery disease.
    Mazur P; Frołow M; Niżankowski R; Sadowski J; Undas A
    Platelets; 2013; 24(2):151-5. PubMed ID: 22497730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer--comparison with two flow cytometric methods.
    Mueller T; Dieplinger B; Poelz W; Calatzis A; Haltmayer M
    Thromb Res; 2007; 121(2):249-58. PubMed ID: 17482663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
    J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events.
    Freynhofer MK; Brozovic I; Bruno V; Farhan S; Vogel B; Jakl G; Willheim M; Hübl W; Wojta J; Huber K
    Thromb Haemost; 2011 Aug; 106(2):230-9. PubMed ID: 21614416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
    Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
    Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
    Gao W; Zhang Q; Ge H; Guo Y; Zhou Z
    Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
    Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
    Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implantation of pipeline flow-diverting stents reduces aneurysm inflow without relevantly affecting static intra-aneurysmal pressure.
    Kerl HU; Boll H; Fiebig T; Figueiredo G; Förster A; Nölte IS; Nonn A; Groden C; Brockmann MA
    Neurosurgery; 2014 Mar; 74(3):321-34; discussion 334. PubMed ID: 24549048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
    Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T
    Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
    Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
    Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patency of the anterior choroidal artery covered with a flow-diverter stent.
    Neki H; Caroff J; Jittapiromsak P; Benachour N; Mihalea C; Ikka L; Moret J; Spelle L
    J Neurosurg; 2015 Dec; 123(6):1540-5. PubMed ID: 26047410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome.
    Caiazzo G; De Rosa S; Torella D; Spaccarotella C; Mongiardo A; Giampà S; Micieli M; Palella E; Gulletta E; Indolfi C
    Circ Cardiovasc Interv; 2014 Feb; 7(1):104-12. PubMed ID: 24449597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment.
    van der Stelt CA; van Werkum JW; Seesing TH; Berg JM; Hackeng CM
    Platelets; 2007 Nov; 18(7):550-3. PubMed ID: 17957573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of ticagrelor for neuroendovascular procedures. A single center initial experience.
    Hanel RA; Taussky P; Dixon T; Miller DA; Sapin M; Nordeen JD; Tawk RG; Navarro R; Johns G; Freeman WD
    J Neurointerv Surg; 2014 May; 6(4):320-2. PubMed ID: 23771209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early angiographic changes of intra-aneurysmal flow after flow-diverter stent treatment are not predictive of therapeutic success.
    Labeyrie PE; Gory B; Sadeh-Gonike U; Huguet N; Sivan-Hoffmann R; Riva R; Courthéoux P; Turjman F
    Interv Neuroradiol; 2016 Dec; 22(6):682-686. PubMed ID: 27511818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Platelets; 2011; 22(3):188-95. PubMed ID: 21231857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.